|
- JAN 20
- Tesshi Yamada (Cancer Proteomics Project)
Suppression of intestinal polyposis in Mdr1-deficient Apc (Min/+) mice
- Mioko Sugawara (Radiobiology Division)
Specific phosphorylation sites of RB protein by Cdk4 and Cdk2 have different functional uses
- FEB 17
- Atsushi Suzuki (Investigative Treatment Division)
Tumor cell survival, malignancy and metastasis induced by a novel AMPK family member ARK5
Masatoshi Fujita (Virology Division)
Cell cycle regulation of DNA replication in mammalian cells
- MAR 10
- Nguyen Lan Anh (Molecular Oncology Division)
Promyelocytic leukemia (PML) protein interacts and collaborates with AML1 to regulate the development of myeloid cells
Satoshi Kaneko (Cancer Information and Epidemiology Division)
Time trend and projection of cancer mortality and incidence
- APR 21
- Noriko Yanagitani (Biology Division)
Search for human lung adenocarcinoma susceptibility genes
Mitsuko Masutani (Biochemistry Division)
Hypomorphic phenotype of poly(ADP-ribose) glycohydrolase (Parg)-disruption in ES cells is related to early and increased apoptosis after methylmethanesulfonate treatment
- JUN 16
- Atsushi Kaneda (Carcinogenesis Division)
Identification of silencing of nine genes in human gastric cancer and discovery of CpG island hypomethylator phenotype
Ishii Genichiro (Pathology Division, East)
Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction
- JUL 28
- Tatsuhiro Shibata (Pathology Division)
Isolation of EBP50 as a b-catenin binding molecule
Takeji Takamura (Cancer Prevention Basic Research Project)
Formation of mono(ADP-ribosyl)ated DNA adducts and their mutational analysis
- SEP 22
- Eriko Okochi (Carcinogenesis Division)
Development of a detection system of demethylating agents using endogenous CpG island as a marker
Tadashi Kondo (Cancer Proteomics Project)
Tumor marker development by proteomics technology
- OCT 20
- Hitoshi Ichikawa (Cancer Transcriptome Project)
Gene expression signature associated with prognosis of neuroblastoma
Yukihiro Nakanishi (Pathology Division)
Clinicopathological significance of dysadherin expression in various human cancers
- NOV 7
- Yuji Heike (Pharmacology Division)
Pre-clinical study for adoptive transfer of NKT cells
Masato Enari (Radiobiology Division)
Identification of a novel protein that enhances p53-mediated transcription
|
|
